Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),53/90,5.145176601350869e-116,2.7063628923105573e-113,0,0,1424.554054054054,378164.6991901513,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;RPS19;RPS18;RPL37;RPS11;RPL39;RPS13;RPS12;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPS3A;RPSA;RPL37A;RPL24;RPL27;RPL29;RPL10;RPL12;RPL11;RPS3;RPL14;RPL13;RPL15;RPS2;RPS27A;RPL19;RPL41;RPL35A;RPL23A;RPS25;RPS29;RPL27A;RPS20;RPS24;RPS23
cytoplasmic translation (GO:0002181),53/93,6.742182850090634e-115,1.7731940895738369e-112,0,0,1317.51375,346359.7430505193,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;RPS19;RPS18;RPL37;RPS11;RPL39;RPS13;RPS12;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPS3A;RPSA;RPL37A;RPL24;RPL27;RPL29;RPL10;RPL12;RPL11;RPS3;RPL14;RPL13;RPL15;RPS2;RPS27A;RPL19;RPL41;RPL35A;RPL23A;RPS25;RPS29;RPL27A;RPS20;RPS24;RPS23
cotranslational protein targeting to membrane (GO:0006613),53/94,1.5445649710136674e-114,2.708137249177297e-112,0,0,1285.3146341463414,336829.4994303429,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;RPS19;RPS18;RPL37;RPS11;RPL39;RPS13;RPS12;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPS3A;RPSA;RPL37A;RPL24;RPL27;RPL29;RPL10;RPL12;RPL11;RPS3;RPL14;RPL13;RPL15;RPS2;RPS27A;RPL19;RPL41;RPL35A;RPL23A;RPS25;RPS29;RPL27A;RPS20;RPS24;RPS23
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",54/113,1.4008758494103854e-111,1.6160129729821746e-109,0,0,957.0669045495093,244291.18160066937,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;RPS19;RPS18;RPL37;RPS11;RPL39;RPS13;RPS12;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPS3A;RPSA;RPL37A;RPL24;RPL27;PABPC1;RPL29;RPL10;RPL12;RPL11;RPS3;RPL14;RPL13;RPL15;RPS2;RPS27A;RPL19;RPL41;RPL35A;RPL23A;RPS25;RPS29;RPL27A;RPS20;RPS24;RPS23
protein targeting to ER (GO:0045047),53/103,1.5361340047359074e-111,1.6160129729821746e-109,0,0,1053.481,268803.7641429081,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;RPS19;RPS18;RPL37;RPS11;RPL39;RPS13;RPS12;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPS3A;RPSA;RPL37A;RPL24;RPL27;RPL29;RPL10;RPL12;RPL11;RPS3;RPL14;RPL13;RPL15;RPS2;RPS27A;RPL19;RPL41;RPL35A;RPL23A;RPS25;RPS29;RPL27A;RPS20;RPS24;RPS23
peptide biosynthetic process (GO:0043043),54/162,7.763892281849062e-101,6.806345567087678e-99,0,0,521.5526315789474,120223.93711857911,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;RPS19;RPS18;RPL37;RPS11;RPL39;RPS13;RPS12;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPS3A;RPSA;EEF1A1;RPL37A;RPL24;RPL27;RPL29;RPL10;RPL12;RPL11;RPS3;RPL14;RPL13;RPL15;RPS2;RPS27A;RPL19;RPL41;RPL35A;RPL23A;RPS25;RPS29;RPL27A;RPS20;RPS24;RPS23
nuclear-transcribed mRNA catabolic process (GO:0000956),54/171,2.5943598368849977e-99,1.9494761060021552e-97,0,0,481.21457489878543,109236.95215836816,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;RPS19;RPS18;RPL37;RPS11;RPL39;RPS13;RPS12;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPS3A;RPSA;RPL37A;RPL24;RPL27;PABPC1;RPL29;RPL10;RPL12;RPL11;RPS3;RPL14;RPL13;RPL15;RPS2;RPS27A;RPL19;RPL41;RPL35A;RPL23A;RPS25;RPS29;RPL27A;RPS20;RPS24;RPS23
translation (GO:0006412),56/214,2.636716593517941e-98,1.7336411602380464e-96,0,0,412.1608339538347,92605.86431484461,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;EEF1B2;RPL7A;RPS14;RPS19;RPS18;RPL37;RPS11;RPL39;RPS13;RPS12;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPS3A;RPSA;EEF1A1;RPL37A;RPL24;RPL27;RPL29;RPL10;RPL12;RPL11;RPS3;RPL14;RPL13;RPL15;RPS2;RPS27A;RPL19;RPL41;RPL35A;RPL23A;EEF2;RPS25;RPS29;RPL27A;RPS20;RPS24;RPS23
cellular macromolecule biosynthetic process (GO:0034645),56/314,7.595114900060944e-88,4.43892270825784e-86,0,0,251.13178294573643,50377.031369373115,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;EEF1B2;RPL7A;RPS14;RPS19;RPS18;RPL37;RPS11;RPL39;RPS13;RPS12;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPS3A;RPSA;EEF1A1;RPL37A;RPL24;RPL27;RPL29;RPL10;RPL12;RPL11;RPS3;RPL14;RPL13;RPL15;RPS2;RPS27A;RPL19;RPL41;RPL35A;RPL23A;EEF2;RPS25;RPS29;RPL27A;RPS20;RPS24;RPS23
gene expression (GO:0010467),55/356,3.234154028129002e-82,1.701165018795855e-80,0,0,199.23034330011075,37383.22504188439,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;RPS19;RPS18;RPL37;RPS11;RPL39;RPS13;RPS12;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPS3A;RPSA;EEF1A1;RPL37A;RPL24;RPL27;RPL29;RPL10;RPL12;RPL11;RPS3;RPL14;RPL13;RPL15;RPS2;RPS27A;RPL19;RANBP2;RPL41;RPL35A;RPL23A;RPS25;RPS29;RPL27A;RPS20;RPS24;RPS23
cellular protein metabolic process (GO:0044267),54/417,5.638519064438773e-76,2.6962372980861772e-74,0,0,153.17616354936928,26540.350681414184,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;RPS19;RPS18;RPL37;RPS11;RPL39;RPS13;RPS12;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPS3A;RPSA;EEF1A1;RPL37A;RPL24;RPL27;RPL29;RPL10;RPL12;RPL11;RPS3;RPL14;RPL13;RPL15;RPS2;RPS27A;RPL19;RPL41;RPL35A;RPL23A;RPS25;RPS29;RPL27A;RPS20;RPS24;RPS23
rRNA metabolic process (GO:0016072),39/162,1.1440734667081406e-63,5.014855362404016e-62,0,0,184.6857962697274,26766.19216176693,RPL4;RPL5;RPL30;RPL3;RPL32;RPL10;RPL31;RPL34;RPL12;RPLP0;RPL11;RPL10A;RPL9;RPL6;RPL7;RPL7A;RPS14;RPS19;RPL14;RPL13;RPL37;RPL15;RPS2;RPL39;RPL19;RPL41;RPS7;RPL23;RPS6;RPL13A;RPL35A;RPL23A;RPS25;RPL27A;RPL37A;RPL24;RPL27;RPL29;RPS24
rRNA processing (GO:0006364),39/173,2.0565584442001187e-62,8.32115185884048e-61,0,0,169.43086040386305,24065.830955740013,RPL4;RPL5;RPL30;RPL3;RPL32;RPL10;RPL31;RPL34;RPL12;RPLP0;RPL11;RPL10A;RPL9;RPL6;RPL7;RPL7A;RPS14;RPS19;RPL14;RPL13;RPL37;RPL15;RPS2;RPL39;RPL19;RPL41;RPS7;RPL23;RPS6;RPL13A;RPL35A;RPL23A;RPS25;RPL27A;RPL37A;RPL24;RPL27;RPL29;RPS24
ribosome biogenesis (GO:0042254),39/192,1.9035073420986883e-60,7.151749013885072e-59,0,0,148.2479815455594,20385.788590342047,RPL4;RPL5;RPL30;RPL3;RPL32;RPL10;RPL31;RPL34;RPL12;RPLP0;RPL11;RPL10A;RPL9;RPL6;RPL7;RPL7A;RPS14;RPS19;RPL14;RPL13;RPL37;RPL15;RPS2;RPL39;RPL19;RPL41;RPS7;RPL23;RPS6;RPL13A;RPL35A;RPL23A;RPS25;RPL27A;RPL37A;RPL24;RPL27;RPL29;RPS24
ncRNA processing (GO:0034470),39/201,1.3664338515548492e-59,4.7916280394523386e-58,0,0,139.94825708061003,18968.631011955862,RPL4;RPL5;RPL30;RPL3;RPL32;RPL10;RPL31;RPL34;RPL12;RPLP0;RPL11;RPL10A;RPL9;RPL6;RPL7;RPL7A;RPS14;RPS19;RPL14;RPL13;RPL37;RPL15;RPS2;RPL39;RPL19;RPL41;RPS7;RPL23;RPS6;RPL13A;RPL35A;RPL23A;RPS25;RPL27A;RPL37A;RPL24;RPL27;RPL29;RPS24
ribosomal large subunit biogenesis (GO:0042273),13/57,1.4239681057235263e-20,4.681295147566093e-19,0,0,97.90871212121212,4474.257238878611,RPL5;RPL3;RPL10;RPLP0;RPL11;RPL35A;RPL23A;RPL10A;RPL6;RPL7;RPL7A;RPL14;RPL24
ribosome assembly (GO:0042255),12/50,2.3503967863426113e-19,7.27240417421302e-18,0,0,102.96289905090596,4416.54543072564,RPL5;RPS14;RPL3;RPS19;RPL10;RPS5;RPLP0;RPL11;RPL24;RPSA;RPL23A;RPL6
ribonucleoprotein complex assembly (GO:0022618),14/136,5.990867172634665e-17,1.750664518225463e-15,0,0,38.52042233953876,1438.8807009109676,RPL5;RPL3;RPL10;RPS5;RPLP0;RPL11;RPSA;RPL23A;RPL6;RPS14;EIF2S3;RPS19;RPL24;EIF4B
ribonucleoprotein complex biogenesis (GO:0022613),10/60,1.4406153426154254e-14,3.988229843240599e-13,0,0,63.1015873015873,2011.1183215523765,RPL5;RPS25;RPS19;RPS7;RPS6;RPL11;RPL14;RPL35A;RPS24;RPL7
ribosomal large subunit assembly (GO:0000027),8/25,2.1819169859913863e-14,5.738441673157346e-13,0,0,144.1447963800905,4534.216907377477,RPL5;RPL3;RPL10;RPL11;RPLP0;RPL24;RPL23A;RPL6
ribosomal small subunit biogenesis (GO:0042274),8/40,1.4856871272055487e-12,3.721292518619612e-11,0,0,76.51923076923077,2084.012248780044,RPS14;RPS25;RPS19;RPS7;RPS5;RPS6;RPSA;RPS24
negative regulation of ubiquitin protein ligase activity (GO:1904667),4/9,2.0292033573734344e-8,4.851640754447394e-7,0,0,230.97971014492754,4091.3522589236372,RPL5;RPS7;RPL23;RPL11
negative regulation of ubiquitin-protein transferase activity (GO:0051444),4/15,2.1622427376602118e-7,4.944955130475093e-6,0,0,104.95915678524374,1610.8028959018359,RPL5;RPS7;RPL23;RPL11
regulation of translation (GO:0006417),8/178,2.760793255232399e-7,6.050738551051008e-6,0,0,14.30371040723982,216.02289641054435,RPS4X;RPL5;RPL10;RACK1;RPS3;RPL13A;EEF2;EIF4B
ribosomal small subunit assembly (GO:0000028),4/17,3.7493251374531143e-7,7.888580089201353e-6,0,0,88.80267558528428,1313.9705467485358,RPS14;RPS19;RPS5;RPSA
regulation of ubiquitin protein ligase activity (GO:1904666),4/21,9.324995496777678e-7,1.8865183197327147e-5,0,0,67.89428815004263,942.7391564255943,RPL5;RPS7;RPL23;RPL11
positive regulation of signal transduction by p53 class mediator (GO:1901798),4/22,1.1365823115745725e-6,2.2142307255119448e-5,0,0,64.11916264090178,877.6300621626275,RPS7;RPL23;RPS20;RPL37
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),4/26,2.297398734148444e-6,4.3158276220074336e-5,0,0,52.45059288537549,681.0044968744282,RPL5;RPS7;RPL23;RPL11
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),4/38,1.0974145149427353e-5,1.990482878827168e-4,0,0,33.91815856777494,387.3443021760695,RPL5;RPS7;RPL23;RPL11
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),4/42,1.6458303751094902e-5,2.885689257691973e-4,0,0,30.341723874904652,334.2043918986734,RPL5;RPS7;RPL23;RPL11
maturation of LSU-rRNA (GO:0000470),3/26,1.1418925071263456e-4,0.001937533737898251,0,0,37.088198757763976,336.6738132577794,RPL7A;RPL10A;RPL7
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",3/30,1.7645259689293347e-4,0.002900439561427594,0,0,31.58730158730159,272.99193647793965,RPS14;RPS19;RPS8
positive regulation of cellular amide metabolic process (GO:0034250),4/81,2.197438672615484e-4,0.003502584066047711,0,0,14.94447581404103,125.87803606420178,RPS4X;RPL5;RACK1;EEF2
regulation of signal transduction by p53 class mediator (GO:1901796),5/156,2.652815299768441e-4,0.0041040613167005885,0,0,9.62991819244254,79.29966952416879,RPL5;RPL23;RPL11;RPS20;RPL37
maturation of SSU-rRNA (GO:0030490),3/35,2.8075503769816495e-4,0.004219347137978136,0,0,26.645089285714285,217.90428679505138,RPS14;RPS19;RPS8
positive regulation of gene expression (GO:0010628),8/482,3.658751290068803e-4,0.00534584216271164,0,0,5.051087309315157,39.970357340932765,RPS4X;RPL5;RPS7;RPL23;RPL11;RPS3;EEF2;ACTB
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),3/40,4.183063282338499e-4,0.00594673320678392,0,0,23.038610038610038,179.2241796171757,RPS7;RACK1;RPS3
positive regulation of translation (GO:0045727),4/100,4.915838573587474e-4,0.006804555499228978,0,0,11.97524154589372,91.22592932976644,RPS4X;RPL5;EIF2S3;EEF2
translational elongation (GO:0006414),4/104,5.701532232888839e-4,0.007443788851673356,0,0,11.49391304347826,85.85499517199727,EEF1B2;EEF1A1;RACK1;EEF2
formation of translation preinitiation complex (GO:0001731),2/10,5.802192831152235e-4,0.007443788851673356,0,0,70.13732394366197,522.670663979618,EIF2S3;EIF4B
regulation of protein neddylation (GO:2000434),2/10,5.802192831152235e-4,0.007443788851673356,0,0,70.13732394366197,522.670663979618,RPL5;RPL11
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),3/55,0.001068071594490535,0.013376325207190986,0,0,16.380494505494507,112.07371362357779,RPL5;RPL11;RPS3
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),3/64,0.0016568622589987344,0.020267663912403124,0,0,13.957377049180328,89.36670789604038,RPL30;RPS19;RPL39
cytoplasmic translational initiation (GO:0002183),2/19,0.002158469583729576,0.025803522750949024,0,0,32.99088649544325,202.50980060332466,EIF2S3;EIF4B
positive regulation of embryonic development (GO:0040019),2/20,0.0023926495225994084,0.027967414419717528,0,0,31.156494522691705,188.04047198052453,CFL1;RACK1
negative regulation of cellular amide metabolic process (GO:0034249),3/86,0.0038433323361367934,0.04394766975669464,0,0,10.246471600688468,56.98488590691847,RACK1;RPS3;RPL13A
protein stabilization (GO:0050821),4/179,0.0041774565866004336,0.04675196094791124,0,0,6.543105590062112,35.84347717692471,RPL5;RPS7;RPL23;RPL11
negative regulation of translation (GO:0017148),3/90,0.004366309518939849,0.04784747514504918,0,0,9.773399014778326,53.10705845616846,RACK1;RPS3;RPL13A
negative regulation of cellular protein metabolic process (GO:0032269),3/94,0.004930474158446077,0.052927130762094626,0,0,9.341915227629514,49.62724419848809,RACK1;RPS3;RPL13A
positive regulation of cellular protein metabolic process (GO:0032270),3/102,0.006185874782338917,0.0650754027102054,0,0,8.583549783549783,43.65152952506157,RPS4X;RPL5;EEF2
negative regulation of gene expression (GO:0010629),5/322,0.006449652947434947,0.06651995000687808,0,0,4.548617554277231,22.941994069284657,RACK1;RPS3;RPL13A;RPS13;H3-3A
regulation of protein binding (GO:0043393),3/118,0.009226077002968196,0.09332531737617829,0,0,7.383354037267081,34.596339629169705,RPL11;RACK1;ACTB
positive regulation of macromolecule biosynthetic process (GO:0010557),3/129,0.011742298897381983,0.11653677773628156,0,0,6.735034013605442,29.93424705767659,RPS4X;RPL5;EEF2
erythrocyte differentiation (GO:0030218),2/46,0.012260986149212767,0.11725961299065302,0,0,12.729193341869399,56.02541764199213,RPS14;RPS19
interleukin-12-mediated signaling pathway (GO:0035722),2/46,0.012260986149212767,0.11725961299065302,0,0,12.729193341869399,56.02541764199213,RPLP0;CFL1
positive regulation of macromolecule metabolic process (GO:0010604),5/384,0.01315275303761645,0.12273573106777069,0,0,3.792487971441875,16.425736377458524,RPL5;RPS7;RPL23;RPL11;RPS3
cellular response to interleukin-12 (GO:0071349),2/48,0.01330025983053789,0.12273573106777069,0,0,12.174525413349663,52.59360534174025,RPLP0;CFL1
myeloid cell differentiation (GO:0030099),2/52,0.015489228344894771,0.1342330934963045,0,0,11.19830985915493,46.67019310326785,RPS14;RPS19
regulation of gene silencing by RNA (GO:0060966),2/55,0.017225308933891778,0.1342330934963045,0,0,10.562848790858357,42.89969557500649,RANBP2;H3-3A
regulation of posttranscriptional gene silencing (GO:0060147),2/55,0.017225308933891778,0.1342330934963045,0,0,10.562848790858357,42.89969557500649,RANBP2;H3-3A
Rho protein signal transduction (GO:0007266),2/56,0.017821596510184588,0.1342330934963045,0,0,10.366718831507564,41.75034568511572,ARHGDIB;CFL1
regulation of respiratory burst involved in inflammatory response (GO:0060264),1/5,0.018118915662048707,0.1342330934963045,0,0,69.17708333333333,277.45536435713205,RPS19
positive regulation of deoxyribonuclease activity (GO:0032077),1/5,0.018118915662048707,0.1342330934963045,0,0,69.17708333333333,277.45536435713205,RPS3
negative regulation of hydrogen peroxide-induced neuron death (GO:1903208),1/5,0.018118915662048707,0.1342330934963045,0,0,69.17708333333333,277.45536435713205,RACK1
rescue of stalled ribosome (GO:0072344),1/5,0.018118915662048707,0.1342330934963045,0,0,69.17708333333333,277.45536435713205,RACK1
positive regulation of Golgi to plasma membrane protein transport (GO:0042998),1/5,0.018118915662048707,0.1342330934963045,0,0,69.17708333333333,277.45536435713205,RACK1
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255),1/5,0.018118915662048707,0.1342330934963045,0,0,69.17708333333333,277.45536435713205,RPS7
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),1/5,0.018118915662048707,0.1342330934963045,0,0,69.17708333333333,277.45536435713205,RPS3
positive regulation of mitochondrial depolarization (GO:0051901),1/5,0.018118915662048707,0.1342330934963045,0,0,69.17708333333333,277.45536435713205,RACK1
cellular response to antibiotic (GO:0071236),1/5,0.018118915662048707,0.1342330934963045,0,0,69.17708333333333,277.45536435713205,RPL23
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026),1/5,0.018118915662048707,0.1342330934963045,0,0,69.17708333333333,277.45536435713205,TMSB4X
regulation of apoptotic process (GO:0042981),7/742,0.01844114813376766,0.1347228321994693,0,0,2.7694083694083695,11.058720632813078,RPL10;CFL1;RPS6;RACK1;RPS3;RPS3A;RPS27A
positive regulation of apoptotic signaling pathway (GO:2001235),2/59,0.01966226345815744,0.1416760353286413,0,0,9.819619471213244,38.581815562195835,RACK1;RPS3
protein-DNA complex subunit organization (GO:0071824),1/6,0.02170366274746418,0.14636059750213024,0,0,55.33888888888889,211.9631207182121,RPL23
negative regulation of trophoblast cell migration (GO:1901164),1/6,0.02170366274746418,0.14636059750213024,0,0,55.33888888888889,211.9631207182121,ARHGDIB
macromolecule biosynthetic process (GO:0009059),1/6,0.02170366274746418,0.14636059750213024,0,0,55.33888888888889,211.9631207182121,RPS23
chitin catabolic process (GO:0006032),1/6,0.02170366274746418,0.14636059750213024,0,0,55.33888888888889,211.9631207182121,CHI3L2
chitin metabolic process (GO:0006030),1/6,0.02170366274746418,0.14636059750213024,0,0,55.33888888888889,211.9631207182121,CHI3L2
amyloid fibril formation (GO:1990000),2/63,0.022234793704465437,0.14804432263985848,0,0,9.173862849226506,34.91661125444899,RPS27A;H3-3A
regulation of gene silencing by miRNA (GO:0060964),2/67,0.024938561718208668,0.15459202571092906,0,0,8.607583965330445,31.77351908127924,RANBP2;H3-3A
negative regulation of DNA repair (GO:0045738),1/7,0.025275502302547336,0.15459202571092906,0,0,46.113425925925924,169.6014749165987,RPS3
positive regulation of gastrulation (GO:2000543),1/7,0.025275502302547336,0.15459202571092906,0,0,46.113425925925924,169.6014749165987,RACK1
response to host defenses (GO:0052200),1/7,0.025275502302547336,0.15459202571092906,0,0,46.113425925925924,169.6014749165987,RPS27A
positive regulation of membrane depolarization (GO:1904181),1/7,0.025275502302547336,0.15459202571092906,0,0,46.113425925925924,169.6014749165987,RACK1
positive regulation of respiratory burst (GO:0060267),1/7,0.025275502302547336,0.15459202571092906,0,0,46.113425925925924,169.6014749165987,RPS19
modulation by symbiont of host defense response (GO:0052031),1/7,0.025275502302547336,0.15459202571092906,0,0,46.113425925925924,169.6014749165987,RPS27A
positive regulation of cellular process (GO:0048522),6/625,0.026483136704611186,0.15798892098404171,0,0,2.793335423046319,10.143291152354797,RPS4X;RPS19;RPL23;RPS6;IL7R;H3-3A
defense response to bacterium (GO:0042742),3/176,0.02659241096977352,0.15798892098404171,0,0,4.89364161849711,17.749871415843856,RPL30;RPS19;RPL39
positive regulation of apoptotic process (GO:0043065),4/310,0.026737068751666874,0.15798892098404171,0,0,3.717154494648101,13.462434542201336,RPS6;RACK1;RPS3;RPS27A
positive regulation of cellular biosynthetic process (GO:0031328),3/180,0.028167881194378307,0.15798892098404171,0,0,4.782082324455206,17.06999154214803,RPS4X;RPL5;EEF2
regulation of chaperone-mediated autophagy (GO:1904714),1/8,0.028834479875414456,0.15798892098404171,0,0,39.523809523809526,140.15867684434946,EEF1A1
regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),1/8,0.028834479875414456,0.15798892098404171,0,0,39.523809523809526,140.15867684434946,RACK1
regulation of endodeoxyribonuclease activity (GO:0032071),1/8,0.028834479875414456,0.15798892098404171,0,0,39.523809523809526,140.15867684434946,RPS3
regulation of Golgi to plasma membrane protein transport (GO:0042996),1/8,0.028834479875414456,0.15798892098404171,0,0,39.523809523809526,140.15867684434946,RACK1
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),1/8,0.028834479875414456,0.15798892098404171,0,0,39.523809523809526,140.15867684434946,RPS7
cytoplasmic sequestering of NF-kappaB (GO:0007253),1/8,0.028834479875414456,0.15798892098404171,0,0,39.523809523809526,140.15867684434946,TMSB4X
defense response to Gram-negative bacterium (GO:0050829),2/73,0.029231027112912242,0.15851051815867875,0,0,7.877802023408054,27.828529138152547,RPL30;RPS19
negative regulation of protein binding (GO:0032091),2/74,0.02997323503031055,0.1608767512851362,0,0,7.767996870109546,27.24586420461107,RACK1;ACTB
protein import into nucleus (GO:0006606),2/76,0.031480047231749624,0.16377131855348448,0,0,7.5572896840502475,26.136140883906528,RANBP2;RPL23
positive regulation of ATP biosynthetic process (GO:2001171),1/9,0.03238064093072697,0.16377131855348448,0,0,34.58159722222222,118.62160586885466,TMSB4X
regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),1/9,0.03238064093072697,0.16377131855348448,0,0,34.58159722222222,118.62160586885466,TMSB4X
regulation of transmembrane transporter activity (GO:0022898),1/9,0.03238064093072697,0.16377131855348448,0,0,34.58159722222222,118.62160586885466,ACTB
glucosamine-containing compound catabolic process (GO:1901072),1/9,0.03238064093072697,0.16377131855348448,0,0,34.58159722222222,118.62160586885466,CHI3L2
positive regulation of ligase activity (GO:0051351),1/9,0.03238064093072697,0.16377131855348448,0,0,34.58159722222222,118.62160586885466,TMSB4X
regulation of NIK/NF-kappaB signaling (GO:1901222),2/80,0.03458150772275027,0.16989409645158451,0,0,7.168291802094619,24.117260421614933,TMSB4X;RPS3
adherens junction assembly (GO:0034333),1/10,0.03591403083014349,0.16989409645158451,0,0,30.737654320987655,102.25271781730339,ACTB
apical protein localization (GO:0045176),1/10,0.03591403083014349,0.16989409645158451,0,0,30.737654320987655,102.25271781730339,ACTB
regulation of endoplasmic reticulum unfolded protein response (GO:1900101),1/10,0.03591403083014349,0.16989409645158451,0,0,30.737654320987655,102.25271781730339,RACK1
sequestering of actin monomers (GO:0042989),1/10,0.03591403083014349,0.16989409645158451,0,0,30.737654320987655,102.25271781730339,TMSB4X
modification-dependent macromolecule catabolic process (GO:0043632),1/10,0.03591403083014349,0.16989409645158451,0,0,30.737654320987655,102.25271781730339,RPS27A
modulation by symbiont of host process (GO:0044003),1/10,0.03591403083014349,0.16989409645158451,0,0,30.737654320987655,102.25271781730339,RPS27A
"regulation of gene expression, epigenetic (GO:0040029)",2/82,0.0361751688261929,0.16989409645158451,0,0,6.988380281690141,23.197106089070086,ACTB;H3-3A
actin filament depolymerization (GO:0030042),1/11,0.039434694821538385,0.17142685517462142,0,0,27.6625,89.43588520720674,CFL1
rDNA heterochromatin assembly (GO:0000183),1/11,0.039434694821538385,0.17142685517462142,0,0,27.6625,89.43588520720674,H3-3A
positive regulation of ceramide biosynthetic process (GO:2000304),1/11,0.039434694821538385,0.17142685517462142,0,0,27.6625,89.43588520720674,RACK1
positive regulation of histone exchange (GO:1900051),1/11,0.039434694821538385,0.17142685517462142,0,0,27.6625,89.43588520720674,H3-3A
negative regulation of oxidative stress-induced neuron death (GO:1903204),1/11,0.039434694821538385,0.17142685517462142,0,0,27.6625,89.43588520720674,RACK1
regulation of histone exchange (GO:1900049),1/11,0.039434694821538385,0.17142685517462142,0,0,27.6625,89.43588520720674,H3-3A
positive regulation of sphingolipid biosynthetic process (GO:0090154),1/11,0.039434694821538385,0.17142685517462142,0,0,27.6625,89.43588520720674,RACK1
regulation of mitochondrial depolarization (GO:0051900),1/11,0.039434694821538385,0.17142685517462142,0,0,27.6625,89.43588520720674,RACK1
positive regulation by host of viral process (GO:0044794),1/11,0.039434694821538385,0.17142685517462142,0,0,27.6625,89.43588520720674,CFL1
negative regulation of binding (GO:0051100),2/88,0.04112206669644483,0.1772967793633605,0,0,6.498853586636096,20.739209147060983,RACK1;ACTB
modulation by host of viral process (GO:0044788),1/12,0.042942678013426154,0.18216006963759804,0,0,25.146464646464647,79.15828251915687,CFL1
morphogenesis of a polarized epithelium (GO:0001738),1/12,0.042942678013426154,0.18216006963759804,0,0,25.146464646464647,79.15828251915687,ACTB
positive regulation of cellular component biogenesis (GO:0044089),2/92,0.04455352704051626,0.18646107895082503,0,0,6.208763693270735,19.3158609487384,RACK1;RPS3
regulation of receptor signaling pathway via STAT (GO:1904892),1/13,0.04643802536608,0.18646107895082503,0,0,23.04976851851852,70.7544140609547,IL7R
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),1/13,0.04643802536608,0.18646107895082503,0,0,23.04976851851852,70.7544140609547,RACK1
negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/13,0.04643802536608,0.18646107895082503,0,0,23.04976851851852,70.7544140609547,RACK1
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),1/13,0.04643802536608,0.18646107895082503,0,0,23.04976851851852,70.7544140609547,PABPC1
positive regulation of purine nucleotide biosynthetic process (GO:1900373),1/13,0.04643802536608,0.18646107895082503,0,0,23.04976851851852,70.7544140609547,TMSB4X
DNA replication-independent nucleosome organization (GO:0034724),1/13,0.04643802536608,0.18646107895082503,0,0,23.04976851851852,70.7544140609547,H3-3A
positive regulation of intracellular signal transduction (GO:1902533),5/546,0.04920317641323806,0.19166665099372313,0,0,2.634826573882788,7.935563024535349,RPL23;RACK1;RPS3;RPS20;RPL37
regulation of trophoblast cell migration (GO:1901163),1/14,0.04992078172269975,0.19166665099372313,0,0,21.275641025641026,63.76985958511893,ARHGDIB
regulation of gastrulation (GO:0010470),1/14,0.04992078172269975,0.19166665099372313,0,0,21.275641025641026,63.76985958511893,RACK1
"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",1/14,0.04992078172269975,0.19166665099372313,0,0,21.275641025641026,63.76985958511893,RPL7
positive regulation of T cell receptor signaling pathway (GO:0050862),1/14,0.04992078172269975,0.19166665099372313,0,0,21.275641025641026,63.76985958511893,RPS3
cytoplasmic sequestering of transcription factor (GO:0042994),1/14,0.04992078172269975,0.19166665099372313,0,0,21.275641025641026,63.76985958511893,TMSB4X
negative regulation of programmed cell death (GO:0043069),4/381,0.050620312852941496,0.19169569568287678,0,0,3.0061892130857646,8.968671943212227,RPL10;CFL1;RPS3A;RPS27A
establishment of spindle localization (GO:0051293),1/15,0.05339099174661933,0.19169569568287678,0,0,19.754960317460316,57.88427080418689,CFL1
positive regulation of chromatin organization (GO:1905269),1/15,0.05339099174661933,0.19169569568287678,0,0,19.754960317460316,57.88427080418689,H3-3A
positive regulation of endothelial cell chemotaxis (GO:2001028),1/15,0.05339099174661933,0.19169569568287678,0,0,19.754960317460316,57.88427080418689,TMSB4X
regulation of endothelial cell chemotaxis (GO:2001026),1/15,0.05339099174661933,0.19169569568287678,0,0,19.754960317460316,57.88427080418689,TMSB4X
"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",1/15,0.05339099174661933,0.19169569568287678,0,0,19.754960317460316,57.88427080418689,PABPC1
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",1/15,0.05339099174661933,0.19169569568287678,0,0,19.754960317460316,57.88427080418689,PABPC1
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),1/15,0.05339099174661933,0.19169569568287678,0,0,19.754960317460316,57.88427080418689,PABPC1
protein localization to cell-cell junction (GO:0150105),1/15,0.05339099174661933,0.19169569568287678,0,0,19.754960317460316,57.88427080418689,ACTB
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),2/102,0.05357275145510054,0.19169569568287678,0,0,5.585070422535211,16.34590775388441,RPL11;RACK1
regulation of ATP biosynthetic process (GO:2001169),1/16,0.056848699968537475,0.19544062865000467,0,0,18.437037037037037,52.8656580429068,TMSB4X
negative regulation of immune effector process (GO:0002698),1/16,0.056848699968537475,0.19544062865000467,0,0,18.437037037037037,52.8656580429068,RPS19
regulation of ceramide biosynthetic process (GO:2000303),1/16,0.056848699968537475,0.19544062865000467,0,0,18.437037037037037,52.8656580429068,RACK1
regulation of establishment of cell polarity (GO:2000114),1/16,0.056848699968537475,0.19544062865000467,0,0,18.437037037037037,52.8656580429068,RACK1
negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,0.056848699968537475,0.19544062865000467,0,0,18.437037037037037,52.8656580429068,TMSB4X
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1/16,0.056848699968537475,0.19544062865000467,0,0,18.437037037037037,52.8656580429068,RPS3
chromosome organization (GO:0051276),2/106,0.05734735211464239,0.19587472215780455,0,0,5.369176598049838,15.348481819745821,RPS27A;H3-3A
membrane organization (GO:0061024),3/242,0.05870440261609241,0.19921623081332004,0,0,3.530424387328153,10.009602392192482,RPS27A;IL7R;ACTB
negative regulation of phagocytosis (GO:0050765),1/17,0.06029395078422422,0.2032988340544996,0,0,17.283854166666668,48.54211057952261,RACK1
negative regulation of interleukin-8 production (GO:0032717),1/18,0.06372678840915502,0.21156941109663027,0,0,16.266339869281047,44.783677915691136,TMSB4X
regulation of establishment or maintenance of cell polarity (GO:0032878),1/18,0.06372678840915502,0.21156941109663027,0,0,16.266339869281047,44.783677915691136,RACK1
positive regulation of cellular component organization (GO:0051130),2/114,0.0651638680782169,0.21156941109663027,0,0,4.9836519114688125,13.609606491431535,RACK1;RPS3
interleukin-7-mediated signaling pathway (GO:0038111),1/19,0.06714725693918218,0.21156941109663027,0,0,15.361882716049383,41.49040525939519,IL7R
negative regulation of RNA metabolic process (GO:0051253),1/19,0.06714725693918218,0.21156941109663027,0,0,15.361882716049383,41.49040525939519,RPS13
negative regulation of RNA splicing (GO:0033119),1/19,0.06714725693918218,0.21156941109663027,0,0,15.361882716049383,41.49040525939519,RPS13
cellular response to interleukin-7 (GO:0098761),1/19,0.06714725693918218,0.21156941109663027,0,0,15.361882716049383,41.49040525939519,IL7R
NLS-bearing protein import into nucleus (GO:0006607),1/19,0.06714725693918218,0.21156941109663027,0,0,15.361882716049383,41.49040525939519,RANBP2
vesicle transport along actin filament (GO:0030050),1/19,0.06714725693918218,0.21156941109663027,0,0,15.361882716049383,41.49040525939519,MYO7B
endoplasmic reticulum mannose trimming (GO:1904380),1/19,0.06714725693918218,0.21156941109663027,0,0,15.361882716049383,41.49040525939519,RPS27A
regulation of protein-containing complex assembly (GO:0043254),2/116,0.06717127690710505,0.21156941109663027,0,0,4.895725228564369,13.220952732952417,RACK1;RPS3
positive regulation of protein-containing complex assembly (GO:0031334),2/118,0.06919918988758013,0.21576825901771687,0,0,4.810830500242837,12.848603124765257,RACK1;RPS3
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),2/119,0.07022071157453855,0.21576825901771687,0,0,4.76947153003491,12.668250444349496,RACK1;RPS3
positive regulation of activated T cell proliferation (GO:0042104),1/20,0.07055540028716217,0.21576825901771687,0,0,14.552631578947368,38.5842224505161,RPS3
protein-DNA complex disassembly (GO:0032986),1/20,0.07055540028716217,0.21576825901771687,0,0,14.552631578947368,38.5842224505161,RPL23
regulation of protein localization to cell periphery (GO:1904375),1/20,0.07055540028716217,0.21576825901771687,0,0,14.552631578947368,38.5842224505161,ACTB
regulation of mRNA catabolic process (GO:0061013),2/122,0.073314949583703,0.21610202186769173,0,0,4.649530516431925,12.149180185807896,PABPC1;RPS27A
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),1/21,0.07395126223609223,0.21610202186769173,0,0,13.824305555555556,36.00331664229168,RPS3
actin filament-based transport (GO:0099515),1/21,0.07395126223609223,0.21610202186769173,0,0,13.824305555555556,36.00331664229168,MYO7B
error-prone translesion synthesis (GO:0042276),1/21,0.07395126223609223,0.21610202186769173,0,0,13.824305555555556,36.00331664229168,RPS27A
negative regulation of peptidyl-serine phosphorylation (GO:0033137),1/21,0.07395126223609223,0.21610202186769173,0,0,13.824305555555556,36.00331664229168,RACK1
innate immune response in mucosa (GO:0002227),1/21,0.07395126223609223,0.21610202186769173,0,0,13.824305555555556,36.00331664229168,RPL39
negative regulation of reproductive process (GO:2000242),1/21,0.07395126223609223,0.21610202186769173,0,0,13.824305555555556,36.00331664229168,ARHGDIB
stress granule assembly (GO:0034063),1/21,0.07395126223609223,0.21610202186769173,0,0,13.824305555555556,36.00331664229168,RPS23
regulation of intracellular signal transduction (GO:1902531),4/437,0.075637862453109,0.21974923813598418,0,0,2.609900592428959,6.738236899832287,RPL5;TMSB4X;ARHGDIB;RPL11
cytokine-mediated signaling pathway (GO:0019221),5/621,0.07640735752724725,0.21974923813598418,0,0,2.305075439266616,5.927907841684327,TMSB4X;RPLP0;CFL1;RPS27A;IL7R
protein targeting (GO:0006605),2/125,0.07645268170890704,0.21974923813598418,0,0,4.5354402839803045,11.660994632947268,NACA;RPL11
error-free translesion synthesis (GO:0070987),1/22,0.07733488642276296,0.21988189328850438,0,0,13.165343915343914,33.69814742858341,RPS27A
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",1/22,0.07733488642276296,0.21988189328850438,0,0,13.165343915343914,33.69814742858341,RPS27A
positive regulation of JUN kinase activity (GO:0043507),1/23,0.08070631631088798,0.22580597010386746,0,0,12.566287878787879,31.62857298179009,RPS3
negative regulation of smoothened signaling pathway (GO:0045879),1/23,0.08070631631088798,0.22580597010386746,0,0,12.566287878787879,31.62857298179009,RACK1
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",1/23,0.08070631631088798,0.22580597010386746,0,0,12.566287878787879,31.62857298179009,RPS27A
heterochromatin assembly (GO:0031507),1/24,0.08406559523720614,0.2291114149988105,0,0,12.019323671497585,29.76174313200534,H3-3A
negative regulation of NIK/NF-kappaB signaling (GO:1901223),1/24,0.08406559523720614,0.2291114149988105,0,0,12.019323671497585,29.76174313200534,TMSB4X
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",1/24,0.08406559523720614,0.2291114149988105,0,0,12.019323671497585,29.76174313200534,RPS27A
"nucleotide-excision repair, DNA gap filling (GO:0006297)",1/24,0.08406559523720614,0.2291114149988105,0,0,12.019323671497585,29.76174313200534,RPS27A
"protein alpha-1,2-demannosylation (GO:0036508)",1/24,0.08406559523720614,0.2291114149988105,0,0,12.019323671497585,29.76174313200534,RPS27A
positive regulation of programmed cell death (GO:0043068),3/286,0.08688241047547969,0.23339652339253017,0,0,2.974861181221605,7.268179880941477,RPS6;RACK1;RPS27A
negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/25,0.08741276636564344,0.23339652339253017,0,0,11.517939814814815,28.070531668147478,RACK1
cellular response to hexose stimulus (GO:0071331),1/25,0.08741276636564344,0.23339652339253017,0,0,11.517939814814815,28.070531668147478,RACK1
negative regulation of actin filament polymerization (GO:0030837),1/25,0.08741276636564344,0.23339652339253017,0,0,11.517939814814815,28.070531668147478,TMSB4X
global genome nucleotide-excision repair (GO:0070911),1/26,0.09074787272717313,0.23513980815021218,0,0,11.056666666666667,26.53235403248719,RPS27A
positive regulation of interleukin-2 production (GO:0032743),1/26,0.09074787272717313,0.23513980815021218,0,0,11.056666666666667,26.53235403248719,RPS3
RNA polyadenylation (GO:0043631),1/26,0.09074787272717313,0.23513980815021218,0,0,11.056666666666667,26.53235403248719,PABPC1
positive regulation of microtubule polymerization or depolymerization (GO:0031112),1/26,0.09074787272717313,0.23513980815021218,0,0,11.056666666666667,26.53235403248719,RPS3
TOR signaling (GO:0031929),1/26,0.09074787272717313,0.23513980815021218,0,0,11.056666666666667,26.53235403248719,RPS6
mRNA polyadenylation (GO:0006378),1/26,0.09074787272717313,0.23513980815021218,0,0,11.056666666666667,26.53235403248719,PABPC1
positive regulation of cellular component movement (GO:0051272),1/27,0.09407095720227293,0.23748128984372394,0,0,10.630876068376068,25.12826467235412,RPS19
stress-activated protein kinase signaling cascade (GO:0031098),1/27,0.09407095720227293,0.23748128984372394,0,0,10.630876068376068,25.12826467235412,RPS27A
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),1/27,0.09407095720227293,0.23748128984372394,0,0,10.630876068376068,25.12826467235412,RPS27A
Ras protein signal transduction (GO:0007265),2/142,0.09499384599585246,0.23748128984372394,0,0,3.9812877263581488,9.371725045177696,ARHGDIB;CFL1
positive regulation of cell population proliferation (GO:0008284),4/474,0.09503674955317065,0.23748128984372394,0,0,2.3998766574159727,5.648089613738546,RPS4X;RPL23;RPS6;IL7R
protein-DNA complex assembly (GO:0065004),2/143,0.0961219327305885,0.23748128984372394,0,0,3.9528518629507543,9.258123611223978,RPS27A;H3-3A
positive regulation of microtubule polymerization (GO:0031116),1/28,0.09738206251623838,0.23748128984372394,0,0,10.236625514403292,23.842260104213242,RPS3
cellular response to epidermal growth factor stimulus (GO:0071364),1/28,0.09738206251623838,0.23748128984372394,0,0,10.236625514403292,23.842260104213242,EEF1A1
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),1/28,0.09738206251623838,0.23748128984372394,0,0,10.236625514403292,23.842260104213242,RPS27A
mucosal immune response (GO:0002385),1/28,0.09738206251623838,0.23748128984372394,0,0,10.236625514403292,23.842260104213242,RPL39
protein depolymerization (GO:0051261),1/28,0.09738206251623838,0.23748128984372394,0,0,10.236625514403292,23.842260104213242,CFL1
regulation of postsynapse organization (GO:0099175),1/28,0.09738206251623838,0.23748128984372394,0,0,10.236625514403292,23.842260104213242,CFL1
regulation of gene expression (GO:0010468),7/1079,0.09814900907923414,0.23748128984372394,0,0,1.865459633649932,4.330232600350397,RPL5;RPS7;RPL23;RPL11;RACK1;RPS3;RPL6
regulation of mRNA stability (GO:0043488),2/146,0.0995293176361152,0.23748128984372394,0,0,3.8699139280125197,8.929064126559682,PABPC1;RPS27A
aggrephagy (GO:0035973),1/29,0.10068123124553315,0.23748128984372394,0,0,9.870535714285714,22.660735221252363,RPS27A
regulation of ubiquitin-protein transferase activity (GO:0051438),1/29,0.10068123124553315,0.23748128984372394,0,0,9.870535714285714,22.660735221252363,RPS2
negative regulation of mRNA catabolic process (GO:1902373),1/29,0.10068123124553315,0.23748128984372394,0,0,9.870535714285714,22.660735221252363,PABPC1
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",1/29,0.10068123124553315,0.23748128984372394,0,0,9.870535714285714,22.660735221252363,RPS27A
positive regulation of viral genome replication (GO:0045070),1/29,0.10068123124553315,0.23748128984372394,0,0,9.870535714285714,22.660735221252363,PABPC1
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/29,0.10068123124553315,0.23748128984372394,0,0,9.870535714285714,22.660735221252363,RPS27A
negative regulation of apoptotic process (GO:0043066),4/485,0.10122143037890495,0.23768960883617857,0,0,2.3436680827985175,5.368042330774676,RPL10;CFL1;RPS3A;RPS27A
positive regulation of hydrolase activity (GO:0051345),2/149,0.10297050722772698,0.2377714524238666,0,0,3.7903612149084984,8.61667617126367,RACK1;RPS3
"negative regulation of gene expression, epigenetic (GO:0045814)",1/30,0.10396850581271733,0.2377714524238666,0,0,9.529693486590038,21.572055090315498,H3-3A
maintenance of blood-brain barrier (GO:0035633),1/30,0.10396850581271733,0.2377714524238666,0,0,9.529693486590038,21.572055090315498,ACTB
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),1/30,0.10396850581271733,0.2377714524238666,0,0,9.529693486590038,21.572055090315498,RPS27A
morphogenesis of an epithelium (GO:0002009),1/30,0.10396850581271733,0.2377714524238666,0,0,9.529693486590038,21.572055090315498,ACTB
regulation of protein localization to membrane (GO:1905475),1/30,0.10396850581271733,0.2377714524238666,0,0,9.529693486590038,21.572055090315498,ACTB
aminoglycan catabolic process (GO:0006026),1/31,0.10724392850313601,0.24004385698999803,0,0,9.211574074074074,20.566214716689423,CHI3L2
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),1/31,0.10724392850313601,0.24004385698999803,0,0,9.211574074074074,20.566214716689423,RPL11
negative regulation of response to DNA damage stimulus (GO:2001021),1/31,0.10724392850313601,0.24004385698999803,0,0,9.211574074074074,20.566214716689423,RPS3
positive regulation of ubiquitin-protein transferase activity (GO:0051443),1/31,0.10724392850313601,0.24004385698999803,0,0,9.211574074074074,20.566214716689423,RPS2
MyD88-independent toll-like receptor signaling pathway (GO:0002756),1/31,0.10724392850313601,0.24004385698999803,0,0,9.211574074074074,20.566214716689423,RPS27A
positive regulation of NF-kappaB transcription factor activity (GO:0051092),2/155,0.10994984918567059,0.24019407768571402,0,0,3.6406149314185767,8.037498201583205,RPS3;RPS27A
regulation of cell morphogenesis (GO:0022604),1/32,0.11050754144475816,0.24019407768571402,0,0,8.913978494623656,19.634566488548145,CFL1
regulation of cellular amide metabolic process (GO:0034248),1/32,0.11050754144475816,0.24019407768571402,0,0,8.913978494623656,19.634566488548145,RPL10
positive regulation of immune effector process (GO:0002699),1/32,0.11050754144475816,0.24019407768571402,0,0,8.913978494623656,19.634566488548145,RPS19
regulation of dendritic spine morphogenesis (GO:0061001),1/32,0.11050754144475816,0.24019407768571402,0,0,8.913978494623656,19.634566488548145,CFL1
cellular response to glucose stimulus (GO:0071333),1/32,0.11050754144475816,0.24019407768571402,0,0,8.913978494623656,19.634566488548145,RACK1
positive regulation of receptor signaling pathway via STAT (GO:1904894),1/32,0.11050754144475816,0.24019407768571402,0,0,8.913978494623656,19.634566488548145,IL7R
cellular response to growth factor stimulus (GO:0071363),2/158,0.11348582495380964,0.24423443826940036,0,0,3.570061394005056,7.768729702384903,EEF1A1;RACK1
positive regulation of ATP metabolic process (GO:1903580),1/33,0.1137593866463937,0.24423443826940036,0,0,8.63498263888889,18.769600161790645,TMSB4X
RNA stabilization (GO:0043489),1/33,0.1137593866463937,0.24423443826940036,0,0,8.63498263888889,18.769600161790645,PABPC1
regulation of activated T cell proliferation (GO:0046006),1/34,0.11699950591866148,0.24715558278399977,0,0,8.372895622895623,17.964764003409375,RPS3
regulation of transmembrane transport (GO:0034762),1/34,0.11699950591866148,0.24715558278399977,0,0,8.372895622895623,17.964764003409375,ACTB
tRNA export from nucleus (GO:0006409),1/34,0.11699950591866148,0.24715558278399977,0,0,8.372895622895623,17.964764003409375,RANBP2
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),1/34,0.11699950591866148,0.24715558278399977,0,0,8.372895622895623,17.964764003409375,RANBP2
regulation of T cell receptor signaling pathway (GO:0050856),1/35,0.12022794098244914,0.25095197205066766,0,0,8.126225490196079,17.21431840365986,RPS3
cellular response to hydrogen peroxide (GO:0070301),1/35,0.12022794098244914,0.25095197205066766,0,0,8.126225490196079,17.21431840365986,RPS3
regulation of JUN kinase activity (GO:0043506),1/35,0.12022794098244914,0.25095197205066766,0,0,8.126225490196079,17.21431840365986,RPS3
negative regulation of DNA metabolic process (GO:0051053),1/36,0.12344473334823387,0.2516741462836086,0,0,7.893650793650794,16.51321534130612,RPS3
regulation of androgen receptor signaling pathway (GO:0060765),1/36,0.12344473334823387,0.2516741462836086,0,0,7.893650793650794,16.51321534130612,H3-3A
positive regulation of innate immune response (GO:0045089),1/36,0.12344473334823387,0.2516741462836086,0,0,7.893650793650794,16.51321534130612,RPS19
retina homeostasis (GO:0001895),1/36,0.12344473334823387,0.2516741462836086,0,0,7.893650793650794,16.51321534130612,ACTB
regulation of embryonic development (GO:0045995),1/36,0.12344473334823387,0.2516741462836086,0,0,7.893650793650794,16.51321534130612,CFL1
platelet aggregation (GO:0070527),1/36,0.12344473334823387,0.2516741462836086,0,0,7.893650793650794,16.51321534130612,ACTB
regulation of actin cytoskeleton reorganization (GO:2000249),1/37,0.12664992444548392,0.25329984889096785,0,0,7.673996913580247,15.85699852450674,ARHGDIB
regulation of transport (GO:0051049),1/37,0.12664992444548392,0.25329984889096785,0,0,7.673996913580247,15.85699852450674,ACTB
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),1/37,0.12664992444548392,0.25329984889096785,0,0,7.673996913580247,15.85699852450674,H3-3A
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",1/37,0.12664992444548392,0.25329984889096785,0,0,7.673996913580247,15.85699852450674,RPS27A
tRNA transport (GO:0051031),1/37,0.12664992444548392,0.25329984889096785,0,0,7.673996913580247,15.85699852450674,RANBP2
regulation of apoptotic signaling pathway (GO:2001233),1/38,0.12984355553611984,0.25579666746067053,0,0,7.466216216216216,15.241720231400874,RPS3
negative regulation of innate immune response (GO:0045824),1/38,0.12984355553611984,0.25579666746067053,0,0,7.466216216216216,15.241720231400874,RPS19
negative regulation of proteasomal protein catabolic process (GO:1901799),1/38,0.12984355553611984,0.25579666746067053,0,0,7.466216216216216,15.241720231400874,RPL11
ncRNA export from nucleus (GO:0097064),1/38,0.12984355553611984,0.25579666746067053,0,0,7.466216216216216,15.241720231400874,RANBP2
regulation of exit from mitosis (GO:0007096),1/39,0.1330256677214299,0.258197421481447,0,0,7.269371345029239,14.663871680193896,RPS27A
"nucleotide-excision repair, DNA incision (GO:0033683)",1/39,0.1330256677214299,0.258197421481447,0,0,7.269371345029239,14.663871680193896,RPS27A
vesicle cytoskeletal trafficking (GO:0099518),1/39,0.1330256677214299,0.258197421481447,0,0,7.269371345029239,14.663871680193896,MYO7B
DNA replication-independent nucleosome assembly (GO:0006336),1/39,0.1330256677214299,0.258197421481447,0,0,7.269371345029239,14.663871680193896,H3-3A
positive regulation of cation channel activity (GO:2001259),1/40,0.13619630195383398,0.260506381191697,0,0,7.082621082621083,14.12032444596875,TMSB4X
bone development (GO:0060348),1/40,0.13619630195383398,0.260506381191697,0,0,7.082621082621083,14.12032444596875,RPL13
negative regulation of protein kinase B signaling (GO:0051898),1/40,0.13619630195383398,0.260506381191697,0,0,7.082621082621083,14.12032444596875,RACK1
regulation of microtubule polymerization (GO:0031113),1/40,0.13619630195383398,0.260506381191697,0,0,7.082621082621083,14.12032444596875,RPS3
supramolecular fiber organization (GO:0097435),3/351,0.13679597493169704,0.26070537251475595,0,0,2.411206896551724,4.796528757053081,MYO7B;RPS27A;H3-3A
regulation of cell development (GO:0060284),1/41,0.1393554990817365,0.26272757174549605,0,0,6.905208333333333,13.60828094132521,RPS19
response to growth factor (GO:0070848),1/41,0.1393554990817365,0.26272757174549605,0,0,6.905208333333333,13.60828094132521,RACK1
JNK cascade (GO:0007254),1/41,0.1393554990817365,0.26272757174549605,0,0,6.905208333333333,13.60828094132521,RPS27A
ATP-dependent chromatin remodeling (GO:0043044),1/42,0.14250329979273732,0.26486479042749056,0,0,6.736449864498645,13.125232380756088,ACTB
regulation of DNA recombination (GO:0000018),1/42,0.14250329979273732,0.26486479042749056,0,0,6.736449864498645,13.125232380756088,IL7R
translesion synthesis (GO:0019985),1/42,0.14250329979273732,0.26486479042749056,0,0,6.736449864498645,13.125232380756088,RPS27A
monocyte chemotaxis (GO:0002548),1/42,0.14250329979273732,0.26486479042749056,0,0,6.736449864498645,13.125232380756088,RPS19
regulation of purine nucleotide metabolic process (GO:1900542),1/43,0.14563974461828222,0.265994811351446,0,0,6.5757275132275135,12.668922941383459,RANBP2
regulation of carbohydrate catabolic process (GO:0043470),1/43,0.14563974461828222,0.265994811351446,0,0,6.5757275132275135,12.668922941383459,RANBP2
cellular glucose homeostasis (GO:0001678),1/43,0.14563974461828222,0.265994811351446,0,0,6.5757275132275135,12.668922941383459,RACK1
substantia nigra development (GO:0021762),1/43,0.14563974461828222,0.265994811351446,0,0,6.5757275132275135,12.668922941383459,ACTB
DNA synthesis involved in DNA repair (GO:0000731),1/43,0.14563974461828222,0.265994811351446,0,0,6.5757275132275135,12.668922941383459,RPS27A
antibacterial humoral response (GO:0019731),1/44,0.14876487394350427,0.26798056059686043,0,0,6.422480620155039,12.237319088031208,RPL39
homotypic cell-cell adhesion (GO:0034109),1/44,0.14876487394350427,0.26798056059686043,0,0,6.422480620155039,12.237319088031208,ACTB
positive regulation of mRNA catabolic process (GO:0061014),1/44,0.14876487394350427,0.26798056059686043,0,0,6.422480620155039,12.237319088031208,PABPC1
mRNA stabilization (GO:0048255),1/44,0.14876487394350427,0.26798056059686043,0,0,6.422480620155039,12.237319088031208,PABPC1
positive regulation of chemotaxis (GO:0050921),1/45,0.15187872804092215,0.2717286086718539,0,0,6.276199494949495,11.828583218714314,TMSB4X
regulation of DNA repair (GO:0006282),1/45,0.15187872804092215,0.2717286086718539,0,0,6.276199494949495,11.828583218714314,RPS3
regulation of DNA metabolic process (GO:0051052),1/46,0.15498134701054317,0.27447874925099564,0,0,6.13641975308642,11.44105094540804,IL7R
postreplication repair (GO:0006301),1/46,0.15498134701054317,0.27447874925099564,0,0,6.13641975308642,11.44105094540804,RPS27A
posttranscriptional regulation of gene expression (GO:0010608),1/46,0.15498134701054317,0.27447874925099564,0,0,6.13641975308642,11.44105094540804,RPL10
cellular response to tumor necrosis factor (GO:0071356),2/194,0.15793011227227205,0.27808119551776683,0,0,2.895393192488263,5.343745410234893,TMSB4X;RPS3
telomere organization (GO:0032200),1/47,0.15807277083614502,0.27808119551776683,0,0,6.002717391304348,11.07321143358293,H3-3A
positive regulation of blood vessel endothelial cell migration (GO:0043536),1/48,0.1611530393681039,0.2797574214773025,0,0,5.874704491725768,10.72369034010183,TMSB4X
positive regulation of DNA repair (GO:0045739),1/48,0.1611530393681039,0.2797574214773025,0,0,5.874704491725768,10.72369034010183,RPS3
regulation of interleukin-2 production (GO:0032663),1/48,0.1611530393681039,0.2797574214773025,0,0,5.874704491725768,10.72369034010183,RPS3
nucleus organization (GO:0006997),1/48,0.1611530393681039,0.2797574214773025,0,0,5.874704491725768,10.72369034010183,RPS19
negative regulation of intracellular signal transduction (GO:1902532),2/198,0.16305775708765646,0.2804573803039609,0,0,2.835728657660247,5.143021556990856,TMSB4X;RACK1
adherens junction organization (GO:0034332),1/49,0.16422219226923945,0.2804573803039609,0,0,5.752025462962963,10.391234958525118,ACTB
response to glucose (GO:0009749),1/49,0.16422219226923945,0.2804573803039609,0,0,5.752025462962963,10.391234958525118,RACK1
response to hydrogen peroxide (GO:0042542),1/49,0.16422219226923945,0.2804573803039609,0,0,5.752025462962963,10.391234958525118,RPS3
regulation of cellular protein metabolic process (GO:0032268),1/49,0.16422219226923945,0.2804573803039609,0,0,5.752025462962963,10.391234958525118,RPL10
actin polymerization or depolymerization (GO:0008154),1/50,0.1672802691231711,0.2829241850764887,0,0,5.634353741496598,10.074701240888364,CFL1
regulation of cellular component movement (GO:0051270),1/50,0.1672802691231711,0.2829241850764887,0,0,5.634353741496598,10.074701240888364,RPS19
regulation of generation of precursor metabolites and energy (GO:0043467),1/50,0.1672802691231711,0.2829241850764887,0,0,5.634353741496598,10.074701240888364,RANBP2
regulation of smoothened signaling pathway (GO:0008589),1/51,0.17032730933834414,0.28441957051418737,0,0,5.521388888888889,9.773042438478246,RACK1
negative regulation of protein ubiquitination (GO:0031397),1/51,0.17032730933834414,0.28441957051418737,0,0,5.521388888888889,9.773042438478246,RPS3
negative regulation of transport (GO:0051051),1/51,0.17032730933834414,0.28441957051418737,0,0,5.521388888888889,9.773042438478246,RACK1
DNA duplex unwinding (GO:0032508),1/51,0.17032730933834414,0.28441957051418737,0,0,5.521388888888889,9.773042438478246,RPS27A
negative regulation of protein-containing complex assembly (GO:0031333),1/52,0.17336335216475413,0.2867582491781782,0,0,5.412854030501089,9.4852991224055,RPL13A
positive regulation of protein localization to plasma membrane (GO:1903078),1/52,0.17336335216475413,0.2867582491781782,0,0,5.412854030501089,9.4852991224055,RACK1
regulation of intrinsic apoptotic signaling pathway (GO:2001242),1/52,0.17336335216475413,0.2867582491781782,0,0,5.412854030501089,9.4852991224055,RACK1
positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/53,0.1763884367943279,0.29084739107779456,0,0,5.308493589743589,9.210590394266864,RPS3
regulation of cyclin-dependent protein kinase activity (GO:1904029),1/54,0.1794026022045267,0.293974357506483,0,0,5.2080712788259955,8.948106135360762,ACTB
regulation of megakaryocyte differentiation (GO:0045652),1/54,0.1794026022045267,0.293974357506483,0,0,5.2080712788259955,8.948106135360762,H3-3A
protein sumoylation (GO:0016925),1/55,0.18240588726064513,0.29521691292030566,0,0,5.111368312757202,8.697100140634774,RANBP2
regulation of blood vessel endothelial cell migration (GO:0043535),1/55,0.18240588726064513,0.29521691292030566,0,0,5.111368312757202,8.697100140634774,TMSB4X
interstrand cross-link repair (GO:0036297),1/55,0.18240588726064513,0.29521691292030566,0,0,5.111368312757202,8.697100140634774,RPS27A
positive regulation of response to DNA damage stimulus (GO:2001022),1/55,0.18240588726064513,0.29521691292030566,0,0,5.111368312757202,8.697100140634774,RPS3
negative regulation of multicellular organismal process (GO:0051241),2/214,0.1838520864545959,0.29641192078305073,0,0,2.6195854371512093,4.436592039790376,RPS19;ARHGDIB
protein-containing complex disassembly (GO:0032984),1/56,0.18539833067989295,0.29641192078305073,0,0,5.0181818181818185,8.456884033052678,RPL23
regulation of ATP metabolic process (GO:1903578),1/56,0.18539833067989295,0.29641192078305073,0,0,5.0181818181818185,8.456884033052678,RANBP2
sensory organ development (GO:0007423),1/56,0.18539833067989295,0.29641192078305073,0,0,5.0181818181818185,8.456884033052678,MYO7B
protein modification by small protein conjugation (GO:0032446),3/409,0.18778615726688472,0.29756115553459345,0,0,2.0606263194933145,3.446297424220312,RANBP2;RACK1;RPS27A
regulation of cell growth (GO:0001558),2/217,0.18779523668304482,0.29756115553459345,0,0,2.582640026203734,4.3192151248107615,RACK1;H3-3A
"positive regulation of gene expression, epigenetic (GO:0045815)",1/57,0.18837997108939092,0.29756115553459345,0,0,4.928323412698413,8.22682185145779,ACTB
cellular response to peptide (GO:1901653),1/57,0.18837997108939092,0.29756115553459345,0,0,4.928323412698413,8.22682185145779,RPL23
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),1/58,0.1913508469464668,0.2986663071033874,0,0,4.841617933723197,8.006325232895135,RACK1
positive regulation of protein binding (GO:0032092),1/58,0.1913508469464668,0.2986663071033874,0,0,4.841617933723197,8.006325232895135,RPL11
nucleosome assembly (GO:0006334),1/58,0.1913508469464668,0.2986663071033874,0,0,4.841617933723197,8.006325232895135,H3-3A
regulation of phagocytosis (GO:0050764),1/58,0.1913508469464668,0.2986663071033874,0,0,4.841617933723197,8.006325232895135,RACK1
response to reactive oxygen species (GO:0000302),1/59,0.19431099654355077,0.30149729847170414,0,0,4.757902298850575,7.794849109690837,RPS3
selective autophagy (GO:0061912),1/59,0.19431099654355077,0.30149729847170414,0,0,4.757902298850575,7.794849109690837,RPS27A
pattern recognition receptor signaling pathway (GO:0002221),1/61,0.20019926964942997,0.3097200465752946,0,0,4.598842592592592,7.39697185422224,RPS27A
I-kappaB kinase/NF-kappaB signaling (GO:0007249),1/62,0.2031274691226287,0.3124124232704757,0,0,4.523224043715847,7.2096643705392935,RPS27A
stress-activated MAPK cascade (GO:0051403),1/62,0.2031274691226287,0.3124124232704757,0,0,4.523224043715847,7.2096643705392935,RPS27A
positive regulation of DNA metabolic process (GO:0051054),1/63,0.2060450943207102,0.31414411481940163,0,0,4.450044802867383,7.029558795380116,RPS3
cellular response to reactive oxygen species (GO:0034614),1/63,0.2060450943207102,0.31414411481940163,0,0,4.450044802867383,7.029558795380116,RPS3
positive regulation of viral process (GO:0048524),1/63,0.2060450943207102,0.31414411481940163,0,0,4.450044802867383,7.029558795380116,PABPC1
pre-replicative complex assembly (GO:0036388),1/64,0.20895218286419356,0.317655630597011,0,0,4.379188712522046,6.8562761216168315,RPS27A
cell-cell junction assembly (GO:0007043),1/66,0.21473490008633264,0.3227158784154599,0,0,4.244017094017094,6.528788087046047,ACTB
positive regulation of T cell proliferation (GO:0042102),1/66,0.21473490008633264,0.3227158784154599,0,0,4.244017094017094,6.528788087046047,RPS3
embryonic organ development (GO:0048568),1/66,0.21473490008633264,0.3227158784154599,0,0,4.244017094017094,6.528788087046047,RPL10
regulation of protein localization (GO:0032880),1/66,0.21473490008633264,0.3227158784154599,0,0,4.244017094017094,6.528788087046047,RACK1
regulation of viral genome replication (GO:0045069),1/67,0.21761060338183918,0.32610591845825476,0,0,4.179503367003367,6.373943403020491,PABPC1
regulation of translational initiation (GO:0006446),1/68,0.22047591937626412,0.32759981240653935,0,0,4.116915422885572,6.224639434669465,EIF4B
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),1/68,0.22047591937626412,0.32759981240653935,0,0,4.116915422885572,6.224639434669465,RPS27A
regulation of myeloid cell differentiation (GO:0045637),1/68,0.22047591937626412,0.32759981240653935,0,0,4.116915422885572,6.224639434669465,H3-3A
positive regulation of MAP kinase activity (GO:0043406),1/69,0.2233308850248216,0.3290533488040789,0,0,4.056168300653595,6.0806052170528995,RPS3
positive regulation of protein polymerization (GO:0032273),1/69,0.2233308850248216,0.3290533488040789,0,0,4.056168300653595,6.0806052170528995,RPS3
positive regulation of protein transport (GO:0051222),1/69,0.2233308850248216,0.3290533488040789,0,0,4.056168300653595,6.0806052170528995,RACK1
establishment of protein localization to membrane (GO:0090150),1/70,0.22617553722407738,0.3299290370710668,0,0,3.997181964573269,5.941586619779507,NACA
carbohydrate homeostasis (GO:0033500),1/70,0.22617553722407738,0.3299290370710668,0,0,3.997181964573269,5.941586619779507,RPS6
defense response to Gram-positive bacterium (GO:0050830),1/70,0.22617553722407738,0.3299290370710668,0,0,3.997181964573269,5.941586619779507,RPL39
positive regulation of DNA-binding transcription factor activity (GO:0051091),2/246,0.22643418703926826,0.3299290370710668,0,0,2.2723389517432464,3.375107183816165,RPS3;RPS27A
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),1/71,0.22900991275740915,0.3318435650424166,0,0,3.9398809523809524,5.807345082506417,ACTB
regulation of glycolytic process (GO:0006110),1/71,0.22900991275740915,0.3318435650424166,0,0,3.9398809523809524,5.807345082506417,RANBP2
Fc-gamma receptor signaling pathway (GO:0038094),1/72,0.23183404813143674,0.3335806417659894,0,0,3.884194053208138,5.677656463396951,ACTB
cell junction organization (GO:0034330),1/72,0.23183404813143674,0.3335806417659894,0,0,3.884194053208138,5.677656463396951,ACTB
positive regulation of signal transduction (GO:0009967),2/252,0.23451406276004397,0.3335806417659894,0,0,2.21712676056338,3.215365300797838,RPS3;IL7R
regulation of Rho protein signal transduction (GO:0035023),1/73,0.23464797994946024,0.3335806417659894,0,0,3.830054012345679,5.552309978509986,ARHGDIB
negative regulation of cell adhesion (GO:0007162),1/73,0.23464797994946024,0.3335806417659894,0,0,3.830054012345679,5.552309978509986,ARHGDIB
chromatin assembly (GO:0031497),1/73,0.23464797994946024,0.3335806417659894,0,0,3.830054012345679,5.552309978509986,H3-3A
transcription-coupled nucleotide-excision repair (GO:0006283),1/73,0.23464797994946024,0.3335806417659894,0,0,3.830054012345679,5.552309978509986,RPS27A
proteolysis involved in cellular protein catabolic process (GO:0051603),1/74,0.23745174446847134,0.3348515216901231,0,0,3.7773972602739727,5.431107245351442,RPS27A
Fc receptor mediated stimulatory signaling pathway (GO:0002431),1/74,0.23745174446847134,0.3348515216901231,0,0,3.7773972602739727,5.431107245351442,ACTB
regulation of cytokine-mediated signaling pathway (GO:0001959),1/74,0.23745174446847134,0.3348515216901231,0,0,3.7773972602739727,5.431107245351442,RACK1
negative regulation of transcription by RNA polymerase II (GO:0000122),4/684,0.23957076658388707,0.3360879490210233,0,0,1.640835464620631,2.3446003450394093,RPS14;RPL10;RPL23;RPS27A
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),1/75,0.2402453780074235,0.3360879490210233,0,0,3.7261636636636637,5.313861393498236,RPS27A
nucleic acid phosphodiester bond hydrolysis (GO:0090305),1/75,0.2402453780074235,0.3360879490210233,0,0,3.7261636636636637,5.313861393498236,RPS27A
regulation of RNA splicing (GO:0043484),1/76,0.24302891658145068,0.33640318453116597,0,0,3.676296296296296,5.200396261462457,RPS13
regulation of cell division (GO:0051302),1/76,0.24302891658145068,0.33640318453116597,0,0,3.676296296296296,5.200396261462457,RACK1
positive regulation of growth (GO:0045927),1/76,0.24302891658145068,0.33640318453116597,0,0,3.676296296296296,5.200396261462457,H3-3A
cell morphogenesis involved in neuron differentiation (GO:0048667),1/76,0.24302891658145068,0.33640318453116597,0,0,3.676296296296296,5.200396261462457,ACTB
cellular component assembly (GO:0022607),2/261,0.24666655535163712,0.34054227851695834,0,0,2.13910489966828,2.9941432741442684,MYO7B;ACTB
axon development (GO:0061564),1/79,0.2513193218281669,0.3415864684279478,0,0,3.534366096866097,4.8810689680161286,ACTB
regulation of cellular response to heat (GO:1900034),1/79,0.2513193218281669,0.3415864684279478,0,0,3.534366096866097,4.8810689680161286,RANBP2
negative regulation of NF-kappaB transcription factor activity (GO:0032088),1/79,0.2513193218281669,0.3415864684279478,0,0,3.534366096866097,4.8810689680161286,TMSB4X
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/79,0.2513193218281669,0.3415864684279478,0,0,3.534366096866097,4.8810689680161286,RACK1
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),1/79,0.2513193218281669,0.3415864684279478,0,0,3.534366096866097,4.8810689680161286,RACK1
mRNA 3'-end processing (GO:0031124),1/79,0.2513193218281669,0.3415864684279478,0,0,3.534366096866097,4.8810689680161286,PABPC1
response to interferon-gamma (GO:0034341),1/80,0.2540628391818678,0.3435399830582582,0,0,3.4894514767932487,4.781154446243804,RPL13A
regulation of protein localization to plasma membrane (GO:1903076),1/80,0.2540628391818678,0.3435399830582582,0,0,3.4894514767932487,4.781154446243804,ACTB
protein deubiquitination (GO:0016579),2/267,0.2547834725331441,0.34363104244213794,0,0,2.0900345469040658,2.8577903910882476,RPS27A;ACTB
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),1/81,0.2567964401726413,0.34457889676226866,0,0,3.445659722222222,4.684276430596063,RACK1
regulation of interleukin-8 production (GO:0032677),1/81,0.2567964401726413,0.34457889676226866,0,0,3.445659722222222,4.684276430596063,TMSB4X
cellular response to cytokine stimulus (GO:0071345),3/482,0.2575729222404856,0.34471617236639146,0,0,1.7400536832687146,2.360300004896268,RPS3;RPL13A;RPS27A
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/82,0.2595201601845837,0.34471617236639146,0,0,3.402949245541838,4.590309327715687,ACTB
positive regulation of protein ubiquitination (GO:0031398),1/82,0.2595201601845837,0.34471617236639146,0,0,3.402949245541838,4.590309327715687,RPS2
ephrin receptor signaling pathway (GO:0048013),1/82,0.2595201601845837,0.34471617236639146,0,0,3.402949245541838,4.590309327715687,ACTB
regulation of defense response (GO:0031347),1/83,0.26223403450441707,0.34744358224010924,0,0,3.361280487804878,4.49913414177752,TMSB4X
anaphase-promoting complex-dependent catabolic process (GO:0031145),1/84,0.2649380981124827,0.34926676593274664,0,0,3.320615796519411,4.410638057386621,RPS27A
spindle assembly (GO:0051225),1/84,0.2649380981124827,0.34926676593274664,0,0,3.320615796519411,4.410638057386621,RPS3
protein modification by small protein removal (GO:0070646),2/276,0.2669711000972081,0.35106699662782864,0,0,2.020458517528529,2.6682475539328974,RPS27A;ACTB
regulation of Ras protein signal transduction (GO:0046578),1/86,0.27031693312159105,0.3519472941137547,0,0,3.242156862745098,4.241260511650994,ARHGDIB
glucose homeostasis (GO:0042593),1/86,0.27031693312159105,0.3519472941137547,0,0,3.242156862745098,4.241260511650994,RPS6
positive regulation of endothelial cell migration (GO:0010595),1/86,0.27031693312159105,0.3519472941137547,0,0,3.242156862745098,4.241260511650994,TMSB4X
positive regulation of proteasomal protein catabolic process (GO:1901800),1/86,0.27031693312159105,0.3519472941137547,0,0,3.242156862745098,4.241260511650994,RACK1
protein targeting to membrane (GO:0006612),1/87,0.2729917741243003,0.35367899800340385,0,0,3.204295865633075,4.1601809509671455,NACA
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/87,0.2729917741243003,0.35367899800340385,0,0,3.204295865633075,4.1601809509671455,RPS27A
sensory perception of mechanical stimulus (GO:0050954),1/88,0.2756569436541569,0.356254428408075,0,0,3.1673052362707534,4.081383649422967,MYO7B
positive regulation of inflammatory response (GO:0050729),1/89,0.27831247612889637,0.35792753653740705,0,0,3.131155303030303,4.004781391662347,RPS19
transforming growth factor beta receptor signaling pathway (GO:0007179),1/89,0.27831247612889637,0.35792753653740705,0,0,3.131155303030303,4.004781391662347,RPS27A
positive regulation of binding (GO:0051099),1/90,0.28095840598002714,0.3594478256813765,0,0,3.0958177278402,3.930291192345841,RPL11
regulation of actin cytoskeleton organization (GO:0032956),1/91,0.2835947674102115,0.3594478256813765,0,0,3.0612654320987653,3.857834050222409,ARHGDIB
sensory perception of sound (GO:0007605),1/91,0.2835947674102115,0.3594478256813765,0,0,3.0612654320987653,3.857834050222409,MYO7B
toll-like receptor signaling pathway (GO:0002224),1/91,0.2835947674102115,0.3594478256813765,0,0,3.0612654320987653,3.857834050222409,RPS27A
positive regulation of supramolecular fiber organization (GO:1902905),1/91,0.2835947674102115,0.3594478256813765,0,0,3.0612654320987653,3.857834050222409,RPS3
positive regulation of transport (GO:0051050),1/91,0.2835947674102115,0.3594478256813765,0,0,3.0612654320987653,3.857834050222409,ACTB
Wnt signaling pathway (GO:0016055),1/92,0.2862215945871041,0.36190518930965565,0,0,3.0274725274725274,3.78733471438743,RPS27A
interleukin-1-mediated signaling pathway (GO:0070498),1/94,0.2914467819279733,0.36587352576160853,0,0,2.9620669056152926,3.6519259376872046,RPS27A
regulation of kinase activity (GO:0043549),1/94,0.2914467819279733,0.36587352576160853,0,0,2.9620669056152926,3.6519259376872046,EEF1A1
nucleosome organization (GO:0034728),1/94,0.2914467819279733,0.36587352576160853,0,0,2.9620669056152926,3.6519259376872046,H3-3A
regulation of cell cycle (GO:0051726),2/296,0.29404566035643653,0.36825718416068004,0,0,1.8810961004119957,2.3024996558344886,RPL23;RACK1
regulation of peptidyl-serine phosphorylation (GO:0033135),1/98,0.301784233455671,0.37705108503012574,0,0,2.839347079037801,3.4016598236456796,RACK1
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),1/99,0.30434526608940626,0.3786059542703967,0,0,2.810232426303855,3.343031356689387,RANBP2
regulation of cell population proliferation (GO:0042127),4/764,0.3044682864189692,0.3786059542703967,0,0,1.4620137299771168,1.7386096907660935,RPS4X;RPL23;RPS6;IL7R
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),1/100,0.30689703311188365,0.3807260363604971,0,0,2.781705948372615,3.2858706369655613,RPS27A
positive regulation of cell growth (GO:0030307),1/102,0.3119729025515113,0.384303856538864,0,0,2.7263476347634765,3.1757559046009254,H3-3A
cell junction assembly (GO:0034329),1/102,0.3119729025515113,0.384303856538864,0,0,2.7263476347634765,3.1757559046009254,ACTB
regulation of protein catabolic process (GO:0042176),1/102,0.3119729025515113,0.384303856538864,0,0,2.7263476347634765,3.1757559046009254,EEF1A1
cellular response to organonitrogen compound (GO:0071417),1/103,0.31449707070442484,0.3856071309802505,0,0,2.6994825708061003,3.1227088439446202,ACTB
chromatin remodeling (GO:0006338),1/103,0.31449707070442484,0.3856071309802505,0,0,2.6994825708061003,3.1227088439446202,ACTB
mRNA transport (GO:0051028),1/104,0.31701210482575165,0.3877869003217334,0,0,2.6731391585760518,3.0709432185690173,RANBP2
nucleotide-excision repair (GO:0006289),1/105,0.3195180375197779,0.3897753519559299,0,0,2.6473023504273505,3.0204172504491282,RPS27A
RNA export from nucleus (GO:0006405),1/106,0.32201490119774046,0.3897753519559299,0,0,2.621957671957672,2.9710908892199424,RANBP2
peptidyl-lysine modification (GO:0018205),1/106,0.32201490119774046,0.3897753519559299,0,0,2.621957671957672,2.9710908892199424,RANBP2
protein localization to nucleus (GO:0034504),1/106,0.32201490119774046,0.3897753519559299,0,0,2.621957671957672,2.9710908892199424,RPL11
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),3/547,0.32234273403199526,0.3897753519559299,0,0,1.5270220588235295,1.7288026133384211,RACK1;RPS3;RPL13A
mRNA export from nucleus (GO:0006406),1/107,0.32450272829700727,0.39148723643171063,0,0,2.5970911949685536,2.922925723869372,RANBP2
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),1/108,0.32698155105541804,0.3935750477234551,0,0,2.5726895119418485,2.8758849031958693,RPS27A
regulation of protein ubiquitination (GO:0031396),1/109,0.3294514015880913,0.39564255076560734,0,0,2.5487397119341564,2.829933058480117,RPS3
cellular response to oxygen-containing compound (GO:1901701),2/323,0.33038305766405457,0.39585760439929996,0,0,1.7205037076038787,1.905462186518402,RPS3;ACTB
response to tumor necrosis factor (GO:0034612),1/110,0.3319123119240805,0.39678608198196896,0,0,2.5252293577981653,2.7850362309498995,RPS3
regulation of Wnt signaling pathway (GO:0030111),1/111,0.33436431399957883,0.3979086632664671,0,0,2.5021464646464646,2.741161803729472,RACK1
regulation of protein serine/threonine kinase activity (GO:0071900),1/111,0.33436431399957883,0.3979086632664671,0,0,2.5021464646464646,2.741161803729472,ACTB
cellular response to transforming growth factor beta stimulus (GO:0071560),1/114,0.341667188006915,0.40568158214816546,0,0,2.435349065880039,2.615365563933378,RPS27A
tumor necrosis factor-mediated signaling pathway (GO:0033209),1/116,0.3464918093592559,0.4104835399165959,0,0,2.3927536231884057,2.536070230713175,TMSB4X
regulation of cellular response to stress (GO:0080135),1/118,0.3512815540389537,0.41522269084154984,0,0,2.351614434947768,2.4601819566297687,RANBP2
cytoskeleton organization (GO:0007010),1/120,0.35603667068127076,0.4198997506240996,0,0,2.3118580765639587,2.387505646738297,CFL1
cellular response to interferon-gamma (GO:0071346),1/121,0.35840132074136116,0.4217429411855838,0,0,2.292476851851852,2.3523148826980154,RPL13A
positive regulation of multicellular organismal process (GO:0051240),2/345,0.35963481943243086,0.42224981031575587,0,0,1.6083439411982097,1.644798910788143,RPS19;CFL1
regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.3631049577034895,0.4244293505600788,0,0,2.2546675774134792,2.2841210819660067,CFL1
cellular response to organic substance (GO:0071310),1/123,0.3631049577034895,0.4244293505600788,0,0,2.2546675774134792,2.2841210819660067,RACK1
cellular response to oxidative stress (GO:0034599),1/125,0.3677745806719697,0.42704068307606197,0,0,2.2180779569892475,2.2187102889200414,RPS3
regulation of phosphorylation (GO:0042325),1/125,0.3677745806719697,0.42704068307606197,0,0,2.2180779569892475,2.2187102889200414,RANBP2
platelet degranulation (GO:0002576),1/125,0.3677745806719697,0.42704068307606197,0,0,2.2180779569892475,2.2187102889200414,TMSB4X
negative regulation of cell growth (GO:0030308),1/126,0.3700967127128955,0.4278480678834792,0,0,2.200222222222222,2.187000914806498,RACK1
negative regulation of growth (GO:0045926),1/126,0.3700967127128955,0.4278480678834792,0,0,2.200222222222222,2.187000914806498,RACK1
microtubule cytoskeleton organization involved in mitosis (GO:1902850),1/128,0.37471576891581854,0.4322379264248257,0,0,2.1653543307086616,2.1254847223511613,RANBP2
DNA-dependent DNA replication (GO:0006261),1/129,0.37701275300585196,0.4339359038973263,0,0,2.1483289930555554,2.0956439410726273,RPS27A
regulation of response to external stimulus (GO:0032101),1/130,0.37930141429119896,0.4356169081160931,0,0,2.131567614125754,2.0663930193377014,TMSB4X
cellular response to hypoxia (GO:0071456),1/131,0.3815817824645011,0.43728108404428667,0,0,2.1150641025641024,2.037716378427825,RPS27A
regulation of cell adhesion (GO:0030155),1/133,0.38611775801475434,0.4396059322851965,0,0,2.082807239057239,1.982026202461866,ARHGDIB
regulation of cell motility (GO:2000145),1/133,0.38611775801475434,0.4396059322851965,0,0,2.082807239057239,1.982026202461866,TMSB4X
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),1/133,0.38611775801475434,0.4396059322851965,0,0,2.082807239057239,1.982026202461866,RPS27A
neuron projection morphogenesis (GO:0048812),1/140,0.4017367625718065,0.4564007281053353,0,0,1.9772182254196642,1.8031404219550526,ACTB
regulation of small GTPase mediated signal transduction (GO:0051056),1/141,0.40393581263923134,0.4579099945005079,0,0,1.9629960317460318,1.779454515429452,ARHGDIB
protein localization to organelle (GO:0033365),1/142,0.4061268899537921,0.4594037507864401,0,0,1.9489755713159969,1.7562016791215977,RPL11
negative regulation of DNA-binding transcription factor activity (GO:0043433),1/143,0.4083100229591629,0.46088212891957014,0,0,1.9351525821596245,1.7333713834165307,TMSB4X
negative regulation of cell migration (GO:0030336),1/144,0.41048524010113935,0.4623452597284782,0,0,1.9215229215229215,1.7109534213850381,ARHGDIB
positive regulation of transferase activity (GO:0051347),1/148,0.41910751443185734,0.47104818929734393,0,0,1.8688586545729402,1.6252114296088644,RPS2
cellular response to organic cyclic compound (GO:0071407),1/150,0.4233718875122574,0.4748264665915723,0,0,1.84358687546607,1.584570882801367,ACTB
actin filament organization (GO:0007015),1/152,0.42760538119135166,0.47753806901624407,0,0,1.8189845474613686,1.5453265355059809,MYO7B
negative regulation of protein phosphorylation (GO:0001933),1/152,0.42760538119135166,0.47753806901624407,0,0,1.8189845474613686,1.5453265355059809,RACK1
cellular response to interleukin-1 (GO:0071347),1/155,0.4338982047853735,0.48353910109556447,0,0,1.7832792207792207,1.4889406460251045,RPS27A
mitotic spindle organization (GO:0007052),1/157,0.4380554613204421,0.48713989990391654,0,0,1.760238603988604,1.4529181106397113,RANBP2
skeletal system development (GO:0001501),1/158,0.44012278319703707,0.4878352944984396,0,0,1.7489384288747345,1.435356458929709,RPL13
regulation of cell migration (GO:0030334),2/408,0.44053567468965554,0.4878352944984396,0,0,1.3544022757233054,1.1102900240979514,TMSB4X;RACK1
regulation of neuron projection development (GO:0010975),1/165,0.45438548760257985,0.5021150556280609,0,0,1.6736957994579946,1.3202268949644533,CFL1
"negative regulation of transcription, DNA-templated (GO:0045892)",4/948,0.4573360622385084,0.5043160770177262,0,0,1.1657455170719724,0.9120056085672386,RPS14;RPL10;RPL23;RPS27A
cellular protein-containing complex assembly (GO:0034622),1/168,0.46038781097201875,0.5066192229524725,0,0,1.6433799068529606,1.2747469135428586,EIF4B
organelle assembly (GO:0070925),2/425,0.4614463496440732,0.5067239664149948,0,0,1.2988379449272467,1.0045076079263098,RPS3;RPS23
positive regulation of developmental process (GO:0051094),1/177,0.4780067388738385,0.5238157180159148,0,0,1.558633207070707,1.1504746282251659,CFL1
regulated exocytosis (GO:0045055),1/180,0.48375266693438546,0.5290101929469578,0,0,1.53227808814401,1.1127120335791283,TMSB4X
negative regulation of cytokine production (GO:0001818),1/182,0.48754858178182003,0.5320550913220691,0,0,1.5151933701657458,1.0884623983617594,TMSB4X
regulation of mitotic cell cycle phase transition (GO:1901990),1/188,0.4987719236575012,0.5431760493661401,0,0,1.4661319073083778,1.0198506713118856,RPS27A
regulation of GTPase activity (GO:0043087),1/189,0.5006187620991769,0.5440608860829897,0,0,1.4582594562647755,1.0089849149873038,RACK1
negative regulation of Wnt signaling pathway (GO:0030178),1/191,0.5042923269515328,0.5469232246938273,0,0,1.4427631578947369,0.9877144535641057,RACK1
negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.50975275351866145,0.5505748426094782,0,0,1.4201208981001727,0.9569193090325593,RACK1
regulation of programmed cell death (GO:0043067),1/194,0.50975275351866145,0.5505748426094782,0,0,1.4201208981001727,0.9569193090325593,RPS3
regulation of cellular macromolecule biosynthetic process (GO:2000112),2/468,0.5122839045785613,0.5521748643613181,0,0,1.1763888049326,0.7868585988413505,RPL10;RPL6
modification-dependent protein catabolic process (GO:0019941),1/201,0.5222641034285848,0.5617810192299296,0,0,1.3699305555555557,0.8898820572278457,RPS27A
neutrophil degranulation (GO:0043312),2/481,0.5270388889006463,0.565760113391306,0,0,1.1436972566085448,0.7325162941973462,EEF1A1;EEF2
regulation of inflammatory response (GO:0050727),1/206,0.5310074444756425,0.5682504431685491,0,0,1.3361788617886179,0.8457734779140917,TMSB4X
neutrophil activation involved in immune response (GO:0002283),2/485,0.5315194259295174,0.5682504431685491,0,0,1.1339923599568424,0.71670078535621,EEF1A1;EEF2
regulation of protein kinase B signaling (GO:0051896),1/207,0.532737078128747,0.568396963683004,0,0,1.3296251348435815,0.8373011974266322,RACK1
neutrophil mediated immunity (GO:0002446),2/488,0.5348613017802797,0.5695081877255609,0,0,1.126818524314612,0.7051042291598681,EEF1A1;EEF2
negative regulation of inflammatory response (GO:0050728),1/212,0.5412913196519876,0.5751903719938293,0,0,1.297788309636651,0.7965794294743186,RPS19
positive regulation of GTPase activity (GO:0043547),1/214,0.5446696016867694,0.576451127740927,0,0,1.28547209181012,0.7810218677225697,RACK1
positive regulation of protein modification process (GO:0031401),1/214,0.5446696016867694,0.576451127740927,0,0,1.28547209181012,0.7810218677225697,RACK1
positive regulation of cell motility (GO:2000147),1/221,0.5563014714015769,0.5875794657775693,0,0,1.244128787878788,0.7296130036525972,RACK1
regulation of autophagy (GO:0010506),1/231,0.5724116615704439,0.6033838356433937,0,0,1.1894323671497584,0.6635805809042602,EEF1A1
protein ubiquitination (GO:0016567),2/525,0.5747523608774797,0.6046394836431087,0,0,1.0451081248485175,0.5787976093053394,RACK1;RPS27A
axonogenesis (GO:0007409),1/240,0.5864167224810847,0.6156790339821367,0,0,1.1441190144119013,0.6106444766195653,ACTB
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",1/251,0.6029207865265241,0.6317456846871548,0,0,1.0931666666666666,0.553108944210178,PABPC1
positive regulation of phosphorylation (GO:0042327),1/253,0.6058509448038474,0.6335538707093911,0,0,1.0843805114638447,0.5434061594950922,RACK1
negative regulation of cellular process (GO:0048523),2/566,0.6160441257878206,0.6429349408023685,0,0,0.9670862051743082,0.4684920355776026,ARHGDIB;RACK1
regulation of protein phosphorylation (GO:0001932),1/266,0.6243838793079437,0.650348357457383,0,0,1.030503144654088,0.48535658187823755,RACK1
negative regulation of signal transduction (GO:0009968),1/267,0.6257733534039627,0.6505074780444355,0,0,1.026576858813701,0.4812253838435193,RACK1
positive regulation of cell migration (GO:0030335),1/269,0.6285371104875038,0.6520917556537021,0,0,1.0188121890547264,0.47309583856881215,RACK1
"mRNA splicing, via spliceosome (GO:0000398)",1/274,0.6353587351405461,0.6578714462282031,0,0,0.9998982498982499,0.45351935204118304,PABPC1
DNA metabolic process (GO:0006259),1/277,0.6393922447224987,0.6607471919922089,0,0,0.9888788244766505,0.4422633683380285,RPS27A
DNA repair (GO:0006281),1/298,0.6664206324529508,0.6873279464122591,0,0,0.9179760568649458,0.3725461039425317,RPS27A
mRNA processing (GO:0006397),1/300,0.6688880670783717,0.6885227461511223,0,0,0.9117428465254552,0.36664694320808056,PABPC1
innate immune response (GO:0045087),1/302,0.6713374985229369,0.6895988204018155,0,0,0.905592469545958,0.3608634666974578,RPL39
MAPK cascade (GO:0000165),1/303,0.6725555035477783,0.6895988204018155,0,0,0.9025478292862399,0.3580142230476063,RPS27A
protein polyubiquitination (GO:0000209),1/314,0.6856632120387587,0.7016709134871343,0,0,0.8703407880724174,0.32843938598968153,RPS27A
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/321,0.6937335889804042,0.7085511996188206,0,0,0.8509982638888889,0.3111822116969913,RPS27A
positive regulation of cytokine production (GO:0001819),1/335,0.7092661430052907,0.7227111744450507,0,0,0.8147455089820359,0.27988499869320943,RPS3
intracellular protein transport (GO:0006886),1/336,0.7103453938937095,0.7227111744450507,0,0,0.8122719734660033,0.27780022905490714,RPL11
cellular response to DNA damage stimulus (GO:0006974),1/350,0.7250464018030376,0.7362440296301115,0,0,0.7791308500477555,0.25050585771152223,RPS3
positive regulation of protein phosphorylation (GO:0001934),1/371,0.7457285599542415,0.7557865559459171,0,0,0.7341216216216216,0.21538658954796258,RACK1
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.7751693954478384,0.7841136577030057,0,0,0.6728701406120761,0.1713623274823037,ACTB
organelle organization (GO:0006996),1/420,0.7882069830184946,0.7957713494582115,0,0,0.6466454521347123,0.15389809650101763,CFL1
regulation of nucleic acid-templated transcription (GO:1903506),1/430,0.7959737784405491,0.8020731943672966,0,0,0.6312483812483812,0.14404395917570684,RPL6
positive regulation of transcription by RNA polymerase II (GO:0045944),1/908,0.966559874105698,0.9706069522342626,0,0,0.2912532157295112,0.009906113938605488,RPS27A
regulation of transcription by RNA polymerase II (GO:0006357),4/2206,0.966916431503334,0.9706069522342626,0,0,0.46663770748594824,0.015699189281933538,RPS14;RPL10;RPL23;RPS27A
"positive regulation of transcription, DNA-templated (GO:0045893)",1/1183,0.9884262325292961,0.9903089491626852,0,0,0.22025991727768376,0.0025641040266925924,RPS27A
"regulation of transcription, DNA-templated (GO:0006355)",1/2244,0.9998311520350863,0.9998311520350863,0,0,0.10950116411551988,1.8490609811436123e-5,RPL6
